These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4526561)

  • 1. [Genetically significant dose from radionuclide investigation in Japan, 1971 (author's transl)].
    Hashizume T; Kato Y; Maruyama T; Kumamoto Y; Nishimura A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1973 Oct; 33(10):818-20. PubMed ID: 4526561
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Yamaguchi H; Nishizawa K; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jul; 39(7):747-60. PubMed ID: 492934
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 2. Estimation of genetically significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):208-15. PubMed ID: 1066647
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hygienic characteristics of genetically significant doses in roentgenolopic studies].
    Stavitskiĭ RV; Dermendzhiev KhT
    Gig Sanit; 1973 Aug; 38(8):48-50. PubMed ID: 4770853
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of the genetically significant dose from x-ray diagnosis in the Province of Varese (author's transl)].
    Mombelli L; Conte L; Inversini G; Pedroli G; Trussoni G; Visconti M
    Radiol Med; 1978 Feb; 64(2):169-78. PubMed ID: 684257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Population doses from beam therapy in Japan 1978. Part 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Matsuzawa H; Maruyama T; Kawachi K; Shiragai A; Noda Y; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 May; 40(5):466-75. PubMed ID: 7422474
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 3. Per caput mean marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):216-24. PubMed ID: 1066648
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significant genetic dose received during diagnostic radiological investigations in Poland in 1976 (author's transl)].
    Nowak B
    Pol Przegl Radiol Med Nukl; 1978; 42(6):487-90. PubMed ID: 748894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiation and leukemia (author's transl)].
    Ichimaru M
    Radioisotopes; 1980 Dec; 29(12):622-31. PubMed ID: 7244311
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estimation of genetically significant dose due to therapeutic radiation in Japan].
    Hashizume T; Kato Y; Maruyama T; Shiragai A; Maruyama S; Takizawa M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1965 Jun; 25(3):192-9. PubMed ID: 5217371
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stochastic risk estimation from medical x-ray diagnostic examinations (author's transl)].
    Hashizume T; Maruyama T; Noda Y; Fukuhisa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 Sep; 40(9):885-97. PubMed ID: 7454536
    [No Abstract]   [Full Text] [Related]  

  • 12. [Population doses from beam-therapy in Japan, 1978. Part 3. Estimation of malignancy significant dose and fatal malignant risk (author's transl)].
    Hashizume T; Matsuzawa H; Maruyama T; Kawachi K; Noda Y; Shiragai A; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Feb; 41(2):158-67. PubMed ID: 7267299
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. I. The number of medical examinations using radiopharmaceuticals (author's transl)].
    Hashizume T; Maruyama T; Tateno Y; Yamaguchi H; Nishizawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Mar; 39(3):267-76. PubMed ID: 440920
    [No Abstract]   [Full Text] [Related]  

  • 14. Summary of gonadal and genetically significant dose from x rays in the United States, 1964.
    Segal P; Brown ML
    Radiol Health Data Rep; 1968 Oct; 9(10):539-43. PubMed ID: 5702089
    [No Abstract]   [Full Text] [Related]  

  • 15. [Population doses from brachytherapy in Japan, 1979 (author's transl)].
    Hashizume T; Maruyama T; Nishizawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 Sep; 40(9):878-84. PubMed ID: 7454535
    [No Abstract]   [Full Text] [Related]  

  • 16. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 1. The number of radiographs, radiographic and fluoroscopic examinations (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976; 36(1):47-55. PubMed ID: 1063369
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estimate of the dose in the marrow and the gonads of patients undergoing neoplastic treatment with telecobalt therapy (author's transl)].
    Mombelli L; Inversini G; Conte L; Favarò L; Cinquepalmi N; Grasso A
    Radiol Med; 1981 Apr; 67(4):235-42. PubMed ID: 7313155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of radiation exposure in X-ray diagnosis (author's transl)].
    Gursky S
    Radiol Diagn (Berl); 1974; 15(4):405-26. PubMed ID: 4619198
    [No Abstract]   [Full Text] [Related]  

  • 19. The genetically significant dose in New Zealand from external beam radiotherapy.
    McEwan AC; Chapman RH
    Australas Radiol; 1977 Sep; 21(3):287-95. PubMed ID: 616288
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetically significant dose from beam therapy in Japan, 1971.
    Hashizume T; Kato Y; Kumamoto Y; Yamaguchi H; Nishizawa K
    Health Phys; 1974 May; 26(5):449-59. PubMed ID: 4209296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.